TAIWAN’S NO. 1 MEDICAL SKINCARE

Company Introduction Presented by Eric Wu

Chairman and CEO 2016

Ticker：6523

Disclaimer

• The information and forecast contained in this presentation and released at the same time, including the information regarding business outlook, financial status, and business forecast, is produced according to the internal data of this Company and the status of overall macroeconomic development.

• The actual operational outcomes, financial status, and sales results in the future may differ from the forecast for various reasons, including but not limited to market demand; changes in policies, laws and regulations, and macroeconomic condition; and other risk factors beyond the reasonable control of this Company.

• Information contained in this presentation reflects the future outlook of this Company until the present time. This Company makes no guarantee, either expressed or implied, for its accuracy, integrity, or reliability. This Company assumes no responsibility for the update or revision of such information according to its future changes or adjustments.

2

DR.WU Company Introduction - Quick Facts About Us

Founded 2003 by Dermatologist

93 Staffs HQ in Taipei and Shanghai

Current Market Cap of US$ 250 mn

1200 POS 7 Countries

12 Product Lines - 68 SKU

Expected IPO June 2016

3

DR.WU Company Introduction - Management Team & Shareholder Structure

Eric I-Ju Wu, Chairman and CEO

In Charge of Company Strategy and Development

Columbia University, BS in Engineering

DR.WU Skincare Co / GM

W Clinic Group / GM

AIG Investment Corp Taiwan / VC Associate

PricewaterhouseCoopers LLP / Senior Financial Analyst

Jennifer Hsu, General Manager

In Charge of Operations, Sales and Marketing

Joined DR.WU in June 2015

MBA in Marketing and Bachelor in International Trade

Clarins Taiwan / GM

Elizabeth Arden Taiwan / GM

Johnson & Johnson (LifeScan) / Director

Coca Cola Taiwan / Marketing Director

Uniliver Taiwan / Marketing Manager

4

Shareholder Stake

Wu I Ju 29.6%

DEF Investment Holdings

18.2%

Donglin Biomedical 8.0%

Wclinic Biotechnology

8.0%

Hsieh Pie Lin 3.9%

L Capital Taiwan Beauty

22.0%

Wei Nien Tzu 1.8%

Fidelity China Special Situations Fund

1.3%

Grandeur Peak Global Reach Fund

0.8%

Grandeur Peak Emerging Markets

Opportunities Fund 0.6%

Public Float 5.8%

67.7%

Leading Medical Skincare Brand – DR.WU - Our Philosophy About Skincare

Taiwan’s No.1 Medical Skincare

DR.WU is a line of highly effective skincare products developed

with advanced patented technologies to target various problems

in Asian skins. Our philosophy behind our pursuit for enhancing

beauty and wellness is through simple, effective products backed

by the latest discovery in Science, Biotechnology and Cosmetics.

We believe in the partnership between innovation and science to

bring about non-surgical solutions in enhancing one’s beauty and

wellness.

5

Leading Medical Skincare Brand – DR.WU - Brand Origin of DR.WU

Renowned Dermatologist and Aesthetic Surgeon in Asia Brand Founder of DR.WU Clinical Professor of National Taiwan University Hospital (NTUH) Founder and Chief Physician of WCLINIC and WSPA

• 1978 Opened his first dermatology clinic • 1981 Institut National de la Santé et de la Recherche Médicale –

Immunology Researcher. • 1990 Developed esthetic medical treatments and dermatology ointments

and emulsion formula • 1996 Developed first Intensive Whitening Serum with Arbutin

1.5 Generation Entrepreneur

Founder of DR.WU SKINCARE CO

Columbia University, School of Engineering and Applied Science

• 1998 PwC Chairman’s Office, Corporate Development Associate

• 2001 Return Taiwan to work for VC funds and started planning for re-organization of family business

• 2003 Founded DR.WU SKINCARE CO and launched first product under the Brand DR.WU

「Create perfect skin

through simple but effective ways」

--Our Philosophy & Goal .

Eric Wu, Chairman & CEO

DR. Wu Ying-Chin

6

Leading Medical Skincare Brand – DR.WU - The Milestones of DR.WU

Full Launch in Cosmed Chain Drugstores DR.WU’s Hydrating and Whitening Serum was recommend by Barbie Hsu “the Beauty Queen”

Launch in SASA, Health Drugstores, Etc.

Expanded business overseas: Hong Kong, U.S.A ,New Zealand and Yahoo! POS of total 500 stores. Product lines add to 6 series .

Launch in Watsons and regional expansion to Singapore. POS of total 900 stores

DR.WU Clinical Skincare brand and the Company were formally incepted

DR.WU’s Total Sales has reached No.1 in Cosmeceuticals Sector and launched over 100 SKU

Set up Department Store Counters in Shinkong Mitsukoshi, becoming the first medical skincare brand having outlets in a department store

Expanded business into Malaysia Have received recognitions from major Beauty Awards

Launched product in Canada Chairman Eric Wu won TOP 100 MVP Managers award

Number of sales points surpasses 1,200 Vitamin C+ Whitening System and UV Protect Suncare System launched Received numerous awards, #1 among local brands Company renamed as DR.WU Skincare

Received investment from L Capital Asia of LVMH Started E-commerce sales channel in China Setup of Medical Skincare Concept Stores in Taipei 101 Chairman Eric Wu received 2014 EY Entrepreneur Of The Year award

Went public and listed on Emerging Stock Market Board Employed Hannah as Global Brand Endorser Received 2015 National Cornerstone Award Received 2015 National Entrepreneur Recognition

2003

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2003

2009

2015 Received Approval for Listing on TPEX 2016

7

Leading Medical Skincare Brand – DR.WU - Competitive Advantages and Our Success Formula

Growth Sales

• 100% penetration in drugstore

chains

• Full coverage of virtual online stores

• Present footprint in overseas

Chinese-speaking market

• First Taiwanese brand entering

cosmeceutical market

• Non-surgical cosmetic medicine

more common and reaching

younger market which drives

growth of cosmeceuticals

• Consumption habits changing from

emotional to rational. Consumers

trying to select cosmeceutical vs

general skincare products

• Cosmeceutical market growing at

double digits

Complete Coverage of Online/Offline Channels

High Potential Markets + Necessity of Skincare

8

Brand

• Market leader: Taiwan’s No.1

Medical Skincare /First to enter the

cosmeceutical market

• High popularity, high reputation,

high reliability from consumers

• One of few Asian cosmeceutical

brands to truly stem from doctors

and clinics

• Only IPO cosmeceutical company

founded by professional teams with

medical background

Leading Cosmeceutical Brand

Product

• Complete product line developed by

authoritative dermatologists with

patented formula in Asia

• 15% new product development rate

• Advanced knowledge and skills in R&D

• 100 patented active ingredients from

global pharmaceutical companies

• 12 full product lines (cyclical, risk

diversification, synergy), satisfying

needs of Asian skin care

• Insist on applying 5 principles to

develop high effectiveness,

hypoallergenic and high quality

products

R&D by Authoritative Dermatologist in Asia

Advanced Clinical Skincare Solutions

- Brand Concept

- Product Portfolio

- Research and Development

9

40 Years of Clinical Studies Fix various skin problems based on 40 years

of clinical experience

Functional Solutions Target Asian Skin Developed specifically for Asian skin type

DR.WU CLINICAL SKINCARE

Taiwan’s No.1 Medical Skincare Brand

Micro- Surgery Concept Skincare

Advanced Clinical Skincare Solution - Brand Concept

High

Po

ten

cy Effective an

d rap

id resu

lt for th

e beau

tiful skin

For Se

nsitive

Skin

Suitab

le for th

e fragile and

tend

er skin after th

e co

smetic su

rgeries

Micro

- Surge

ry Co

nce

pt Skin

care

Co

ncep

t for th

e med

icinal treatm

ent

-Co

ntin

uatio

n o

f med

ical skin care an

d

main

tenan

ce at ho

me

EFFECTIVE

Medical Professional, Scientific Testified

Patented Active Ingredient with Effectiveness

• DR.WU is a professional brand positioned to offer Micro-Surgery Concept Skincare with fast effective functional Skincare.

• Mid to High-end Skincare solutions developed by renowned Asian dermatologist for Asian skins, Targeting 18-40 year old.

TRUST

No Additives. No Alcohol. High Concentration.

High Grade Actives. High Safety Level.

EXCELLENCE

Innovation Technology, Good Quality of Process

CARING

One on one Care, Exclusive Physician,

Customized Programs, Corporate Responsibility

10

12 SERIES- 68 SKU

Average

Retail Price USD 40

HYALUCOMPLEX

HYDRATING SYSTEM

x11 BASIC CARE SYSTEM

x3

UV PROTECT

SUNCARE SYSTEM

x6

MINERAL MAKE UP

x3

PREMIUM SKINCARE

x6

SKINCARE FOR MEN

x5

11

CAPSULE MASK

x8 FIRST AID SERIES

x2

VITAMIN C +

WHITENING SYSTEM

x6

AGEVERSAL

REPAIRING SYSTEM

x6

ACNECUR

ANTI-ACNE SYSTEM

x5

MANDALIK

RENEWAL SYSTEM

x7

35%

25%

12%

7%

Advanced Clinical Skincare Solution - Complete Product Lines: 12 Key Lines x 68 sku

Advanced Clinical Skincare Solution - Research Core Competency & Safety Management

Global Technical Cooperation Laboratories

over 100 international patented active ingredients

Patented Formula

Ying-Chin Wu, M.D. 40 years of clinical experience

Innovative Technology

3 major Microinject Delivery Technology-

Cellulose/Microinject mask

7 major cosmetic manufacturing companies

ISO Certified (ISO9001/ISO022716/GMP)

DR.WU R&D Core Competency

200 Non-Additives

Checks

70 Quality Checks

Accurate Rigorous

Process Clinical Safety

Optimized Quality

Assurance

Feedback DR.WU Safety Management

System

DR.WU is developed based on such principles: No Additives, No Alcohol, High Concentration, High Grade Actives, that are safe and effective even for use on sensitive skins

12

Cooperation Pharmaceutical MNC’s Laboratories / USE over 100 Patented Active Ingredients

3 formulation patents and registered 85 trademarks -HyaluComplex ™– Most advanced hydrating formula -Ageversal ™– Properties of multi-peptides -SensiPhyte™ – Anti-redness soothing factor DR.WU brand was registered over 5 markets -Taiwan, China, Hong Kong, Singapore, US, etc

13

Advanced Clinical Skincare Solution - Active Ingredients and Leading Research Lab Collaboration

Taiwan’s No 1. Medical Skincare Brand

- Brand Positioning and Competitors

- Market Leader in Derma Skincare Sector

- Growth Potential of Derma Skincare

14

Taiwan’s No.1 Medical Skincare Brand - Brand Positioning Among Derma Skincare and Doctors’ Brands

High effectiveness

High price Low price

Low effectiveness

• DR.WU is a PROFESSIONAL brand positioned to offer Non-Surgical Cosmetic Medicine Concept Skincare with fast effective functional skincare

• Mid- to High-end Skincare solutions developed by renowned Asian dermatologist for Asian skins, targeting 18-40-year-old segment

15

16

• DR. WU Sales of drugstores channel grew 38% YOY in 2016Q1, and the growth rate is 2.9x higher than Derma, 38x higher than Caring.

• In Derma Market, DR.WU’s market share is 32%, 2% increase compare to 2015, which is the highest growth rate among Derma brands.

Taiwan’s No.1 Medical Skincare Brand - Market Leader Among Derma Skincare Market

2,218

1,668

550 144

2,230

1,606

624 199

0

200

400

600

800

1,000

1,200

1,400

1,600

1,800

2,000

2,200

2,400

Caring Mass Derma DR. WU

TWD Million 2016Q1 Taiwan Skincare Market

2015Q1 2016Q1

YOY 1%

YOY -4%

YOY 13%

YOY 38% 54% 54% 53% 52% 49%

26% 27% 28% 30% 32%

10% 10% 9% 9% 8%

5% 5% 4% 4% 5% 3% 3% 3% 4% 4%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

2015Q1 2015H1 2015/1-9 2015 2016Q1

2016Q1 Derma Market Share

Others(AVENE、Bio、FOB…..) DR. WU Vichy Curel Neogence

Taiwan’s No.1 Medical Skincare Brand - Taiwan Skincare Market: Mass vs Derma

Taiwan’s skincare market is estimated at NTD 8.6bn in 2015, with 5-year growth rate of 3-5%

17

Annual growth rate of Derma Skincare market estimated at 10-15%, 3x that of Mass market

Caring-Mass Caring-Derma

30% 33% 36% 40%

Taiwan’s No.1 Medical Skincare Brand - Medical Skincare Demand Drivers

Cosmeceutical market driven by changing consumption habits and surge in sensitive skin

• Global climate change leads to surge in number of people with sensitive skin:

In addition, growing popularity of micro-surgery treatments results in increased demand for post-treatment sensitive skin repair. Hence the demand for hypoallergenic, non-irritating skin-care products.

• Consumption habits have migrated from emotional to rational: Main consumer age falls between 29 and 45 year-old women who are more independent

and willing to invest on themselves. They spend wisely and are aware of personal demands. Therefore, strict inspection, scientific experiment, high effectiveness and hypoallergenic skincare products fit the demand from these clever consumers. Product safety is main concern. Hence skincare products with testimonies become increasingly attractive.

• Endorsement by professional teams, equipped with both effectiveness and safety: These are key for persuading consumers. Products with scientific experiment clinical data and approval by dermatologists provide "effectiveness and safety" signs to consumers.

18

Multi-Channel Distribution Strategy - Sales Distribution Network

- Sales Contribution by Channel

- Visual Merchandising

- Marketing and Communication

19

20

China Channel

EC Channel

TMALL JUMEI TAOBAO MEI.COM Cross Border

Department Store SUPER BRAND Shopping Mall, Shanghai

Cosmetic Stores FIONA Beauty

Stores(40)

B&M Channel - Taiwan

Drugstore chains channels Watsons (510) Cosmed (380) Your Chance Pharmacies (36)

Department Store Taipei 101 concept store Far Eastern Mega City

Beauty Specialist SaSa(23)

Others Duty Free Stores(13) W Clinics(4)

EC Channel - Taiwan

DRWU.COM YAHOO MOMOSHOP PCHOME BOOKS PAYEASY, 7net ETMALL

Overseas markets Hong Kong, Macao(370) Singapore(60) Malaysia(62) U.S.A(10) Canada(25) New Zealand

Complete Distribution Coverage of Online and Offline Sale Channels

Direct One Level Two Level

Multi-Channel Distribution Strategy - Regional Sales Channel Distribution

21

B&M

482,689

73%

EC

126,436

19%

China

13,636

2%

Overseas

40,048

6%

Channel 2014 2015 YOY

B&M TW 482,689 531,234 10%

EC TW 126,436 141,163 12%

China 13,636 138,671 917%

Overseas 40,048 54,146 35%

Total 662,809 865,214 31%

B&M

531,234

62%

E Commerce

141,163

16%

China

138,671

16%

Overseas

54,146

6%

2014 Revenue By Channel 2015 Revenue By Channel

NTD 000

Multi-Channel Distribution Strategy - Sales Contribution by Channel

Multi-Channel Distribution Strategy - Medical Skincare Concept Store and Department Store Counter

TAIPEI 101 MEDICAL SKINCARE CONCEPT STORE

22

Far Eastern Mega City DEPARTMENT STORE

Multi-Channel Distribution Strategy - Chain Pharmacies and Personal Care Specialty Stores

COSMED WATSONS

MANNINGS SASA

23

Multi-Channel Distribution Strategy - Duty Free Channel

EVER RICH DUTY FREE STORES

TAIPEI / TAOYUAN / TAICHUNG / KAOSHING / KIMMEN

24

Multi-Channel Distribution Strategy - E-Commerce Sales Channel

DRWU.COM YAHOO PCHOME

MOMOSHOP TMALL JUMEI

25

•Print Ads / Out Door

•Beauty column

•Pop Up Store

•Sampling

• EPR • KOL Management • Vertical Beauty Portals • Video Ads • Short Movies

• Facebook

• WeChat

• Weibo

• Baidu Search

• Word-of-mouth

•Brand launch event/

Media gathering

•Media trip

•PR Editorials

Offline Marketing PR Activities Digital Marketing Social Media

26

Marketing and Communication - 360 Degree All Around Marcom Strategy with Focus on Digital

China Expansion Updates - China Expansion Plan

- DR.WU 2.0 Visual Upgrades

- 2015-2017 Brand Endorser

- Growing Brand Awareness of DR.WU

27

2015 Q3 2015 Q4 2016 Q1 2016 Q2

Our Future Prospects: Market Expansion - China Expansion Strategy: Online and Offline

E Co

mm

erce

2015 Q1 2015 Q2 2016 Q3 2016 Q4

Cross Border EC (JUMEI/TMALL)

TMALL.COM Flagship Store

JD.COM

Other EC platforms

JUMEI.COM Flagship Store

28

FIONA Beauty Stores (41stores)

SUPER BRAND Shopping Mall, Shanghai

Store B

ased

VIP.COM

Other Cosmetic Stores and Department Counters

29

2.0 Concept Store Design & Shanghai Supermall Counter (Oct. 2015) DR.WU 2.0 CONCEPT STORE aims to deliver Lifestyle consumer experiences with light industrial decor to deliver Trendy, Young, Fun and Professional aspects of DR.WU.

Our Future Prospects: Visual Upgrades - Enhance Consumer Counter Experiences with 2.0 Concept Stores

Our Future Prospects: Brand Endorser - Brand Endorser for 2016: Hannah Quinlivan

Continue Endorser in 2016, DR.WU has Successfully

Enhanced Brand Awareness throughout ASIA:

Hannah's marriage to Jay Chu who is the most popular

singer in Asia and her recent has children announcement

has created tremendous online chatter and followers.

30

Videos of Hannah sharing her beauty tips using DR.WU Serum and Mask during New York Fashion Week, attracting 34,822,000 Unique Visitors.

31

Taiwan’s No.1 Medical Skincare Brand - Growing Brand Awareness in Taiwan and China

Brand Awareness, Positive Word of Mouth and Client Loyalty have surged coupled with Increasing attention from media

61,062

28,642

154,512

0

20000

40000

60000

80000

100000

120000

140000

160000

180000

Jun

-14

Jul-

14

Au

g-1

4

Sep

-14

Oct

-14

No

v-1

4

De

c-1

4

Jan

-15

Feb

-15

Mar

-15

Ap

r-1

5

May

-15

Jun

-15

Jul-

15

Au

g-1

5

Sep

-15

Oct

-15

No

v-1

5

De

c-1

5

Jan

-16

Feb

-16

Mar

-16

Facebook/Wechat/Weibo Fans

FB Fans Wechat Fans Weibo Fans

0

100

200

300

400

500

600

700

Jun

-14

Jul-

14

Au

g-1

4

Sep

-14

Oct

-14

No

v-1

4

De

c-1

4

Jan

-15

Feb

-15

Mar

-15

Ap

r-1

5

May

-15

Jun

-15

Jul-

15

Au

g-1

5

Sep

-15

Oct

-15

No

v-1

5

De

c-1

5

Jan

-16

Feb

-16

Mar

-16

Baidu/Taobao Index

Baidu Index Taobao Index

34,493

224,544

198,779

050000

100000150000200000250000300000350000400000450000500000

Jun

-14

Jul-

14

Au

g-1

4

Sep

-14

Oct

-14

No

v-1

4

De

c-1

4

Jan

-15

Feb

-15

Mar

-15

Ap

r-1

5

May

-15

Jun

-15

Jul-

15

Au

g-1

5

Sep

-15

Oct

-15

No

v-1

5

De

c-1

5

Jan

-16

Feb

-16

Mar

-16

Jumei/Tmall/.COM Unique Vistors

.com.cn UV Jumei UV Tmall Flagship UV

Our Future Prospects

- Growth Strategy

- Market Expansions

- Product Innovation

32

Our Future Prospects - Growth Strategies: Expand, Innovate and Control

Market Expansion

Focus on market expansion in China and ASEAN countries for the next two years Great potential driving from increasing disposable incomes along with consumption power

Innovative Creation

15% per year new product development rate Continue to develop market leading Cosmeceutical products Focus on functional products in whitening, moisturizing, anti-wrinkle and acne treatments categories

Multi-Channel

Continue diversify sales contribution from pharmacy channel to e-commerce, department counters. Activate O2O sales model to get closer to customers

2016 IPO on TW’s OTC

Enhance organization, finance, management and internal controls Listed on Emerging Stock Exchange on April 30, 2015 Shooting for completion of IPO on TPEX in JUNE 2016

33

Our Future Prospects: Market Expansion - Global Skincare Market Potential

NT$157bn ASEAN skincare market 2.9x Taiwan MKT

Thailand Myanmar Vietnam

Indonesia Philippines

NT$ 54bn Taiwan skincare market #1 brand in Taiwan’s cosmeceutical market

34

Taiwan share by Category

Global share by Category

China share by Category

NT$ 3.3tn global skincare market 62x Taiwan MKT

UK Japan

NT$693bn China skincare market

13x Taiwan MKT

2011 2012 2013 13-'11

14% 14% 14% 0.4%

32% 32% 31% -0.7%

6% 6% 6% -0.3%

14% 14% 14% -0.6%

66% 65% 65% -1.0%

16% 15% 15% -1.2%

11% 12% 13% 1.5%

7% 8% 8% 0.7%

34% 35% 35% 1.0%

100% 100% 100% 0.0%

Store-Based

Retailing

Grocery Retailers

Department Stores

Beauty Specialist

Parapharmacies/Drugstores

SubTotal

Non-Store

Retailing

Direct Selling

Internet Retailing

Homeshopping

SubTotal

TOTAL

Channel

35

•Products renewal rate remain at 15% per year. •Continue to develop high efficacy, non additive, medical skin care products. •Diversified product portfolio, extent product form type and reach new demographic.

．Extent to Cosmetics and Body care

．Develop new products for younger Anti-Agers

．Develop Hand and Foot care

．Develop Scalp and Hair care

．Suitable for Mother & Baby

．Develop Organic and Natural

Skincare concept

1-2 years 2-3 years 3-5 years

Our Future Prospects: Innovative Creation - New Products Development Strategy

• Continuous formula upgrades for current products

2016 2018 2020

Financial Performance - Major Financial Indicators

- Income Statement Summary

- Balance Sheet and Key Indices

- IPO Information Snapshot

36

37

Financial Performance - Major Financial Indicators

NTD 000

662,809 865,214

145,995 234,133 0

200,000

400,000

600,000

800,000

1,000,000

2014 2015 2015Q1 2016Q1

Sales Revenue

30.5%

60.4%

249,159 265,041

39,466 81,690

0

50,000

100,000

150,000

200,000

250,000

300,000

2014 2015 2015Q1 2016Q1

Income from Operations

6.4%

107%

67.44% 68.34% 67.34%

36.10%

26.40% 28.62% 34.79%

24.65% 27.11%

0%

10%

20%

30%

40%

50%

60%

70%

80%

2014 2015 2016Q1

Profitability Metrics Gross margin Net profit margin ROE

294,031 286,476

264,671

12.30% 9.91%

12.59%

200,000

220,000

240,000

260,000

280,000

300,000

0%

2%

4%

6%

8%

10%

12%

14%

2014 2015 2016Q1

Debt ratio & Cash equivalents

Cash equivalents Debt ratio

Financial Performance - Income Statement Summary

38

Unit: NT$ Thousands Consolidated

Item 2014 2015

YOY% 2015Q1 2016Q1

YOY% Amount % Amount % Amount % Amount %

Net Revenue 662,809 100.0% 865,214 100.0% 30.5% 145,995 100.0% 234,133 100.0% 60.4%

Cost of Revenue 215,798 32.6% 273,890 31.7% 26.9% 51,084 35.0% 76,477 32.7% 49.7%

Gross Profit 447,011 67.4% 591,324 68.3% 32.3% 94,911 65.0% 157,656 67.3% 66.1%

Operating Expenses 197,852 29.9% 326,283 37.7% 64.9% 55,445 38.0% 75,966 32.4% 37.0%

Income from Operations 249,159 37.6% 265,041 30.6% 6.4% 39,466 27.0% 81,690 34.9% 107.0%

Non-Op Income & Expenses 43,970 6.6% 8,399 1.0% -80.9% (95) -0.2% (1,882) -0.8% 538.0%

Income before Income Tax 293,129 44.2% 273,440 31.6% -6.7% 39,171 26.8% 79,808 34.1% 103.7%

Income Tax Expense 53,885 8.1% 45,050 5.2% -16.4% 1,536 1.1% 12,789 5.5% 732.6%

Net Income 239,244 36.1% 228,390 26.4% -4.5% 37,635 25.8% 67,019 28.6% 78.1%

Capital Stock 281,938 - 281,938 - - 281,938 - 281,938 - -

EPS (NT$) 8.68 - 8.10 - - 1.33 - 2.38 - -

39

Financial Performance - Balance Sheets & Key Indices

Consolidated Unit: NT$ Thousands

Item 2014 2015 2016Q1

Cash and Cash Equivalents 294,031 286,476 264,671

Accounts Receivable 147,767 155,670 177,756

Inventories 94,705 113,347 135,731

Other Financial Assets 431,000 430,212 507,916

Total Assets 1,023,521 1,060,905 1,169,490

Total Liabilities 125,928 105,168 147,258

Total Shareholders' Equity 897,593 955,737 1,022,232

Key Indices

A/R Turnover Days 62 65 65

Inventory Turnover Days 132 146 161

Current Ratio (%) 800 985 770

ROE(%) 34 24 27

Working Capital 876,968 923,879 986,385

Cash from OP activities 176,220 166,449 56,363

40

Proposed IPO Information Snapshot - IPO Number of Shares, Price, and Timetable

ITEMS SHARES %

IPO New Shares 3,525,000 100%

Employee 353,000 10%

Competitive Auction 2,538,000 72%

Public Subscription 634,000 18%

Capital stock(Present) 28,193,750

Capital stock (After New Shares issue)

31,718,750 -

Capital stock (After Stock Dividend)

45,815,625 -

ITEMS PRICE

Minimum Bid Price (Opening Price)

•The Opening Bid is calculated by law as 30-day average price x 70%

Underwriting price •The minimum Bid price x 130% =Public Subscription=Listing Price

PROSPECTIVE DATE EVENTS

5/26-5/30 Period for bidding

6/4 Tenders shall be opened on the day subsequent

to the closure of the tender

6/3-6/6 Period for public subscription

6/7 Date of withholding of subscription processing fees, subscription payments, and postage for lottery winner notifications.

6/16 Official listing

41

Thank You “Your Personal Doctor For Your Perfect Skin”

-DR.WU

Contact Information

Jennifer Hsu , GM ext. 81

Fiona Chiu, Financial Manager ext. 36

TEL：+886-2-2369-9888

Mobile：+886-905-685-503

E-mail：ir@drwu.com